Trial Profile
Inspiratory Flow Parameters With Placebo Dry Powder Inhalers, Easyhaler and Diskus; an Open, Randomised, Multicentre Study in Patients With Asthma or COPD.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Feb 2012
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- Acronyms SALIF
- 02 Feb 2012 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 02 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Nov 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.